Stay updated with breaking news from Benz Stanger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As the first clinical trial of the drug novobiocin is about to open for patients with cancers carrying BRCA gene mutations, new research at Dana-Farber Cancer Institute shows the drug poses a double threat to tumor cells.
E-Mail IMAGE: Researchers from the University of Pennsylvania used a novel technique based on the CRIPSR-Cas9 system to precisely track the lineage of cancer cells. They found that that one clone (represented... view more Credit: University of Pennsylvania It's often cancer's spread, not the original tumor, that poses the disease's most deadly risk. "And yet metastasis is one of the most poorly understood aspects of cancer biology," says Kamen Simeonov, an M.D.-Ph.D. student at the University of Pennsylvania Perelman School of Medicine. In a new study, a team led by Simeonov and ...